Pages

Tuesday, 5 March 2019

Why MacroGenics Stock Rocketed 70.5% Higher in February


Why MacroGenics Stock Rocketed 70.5% Higher in February



Positive results for its breast cancer drug candidate lit a fire under this small-cap biotech.

No comments:

Post a Comment